Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$12.63 - $24.47 $158,557 - $307,196
12,554 Added 12.39%
113,883 $2.69 Million
Q3 2023

Oct 24, 2023

BUY
$10.86 - $17.62 $37,293 - $60,507
3,434 Added 3.51%
101,329 $1.51 Million
Q2 2023

Jul 25, 2023

BUY
$7.47 - $10.95 $281,887 - $413,209
37,736 Added 62.73%
97,895 $1.07 Million
Q1 2023

Apr 14, 2023

BUY
$5.88 - $9.59 $353,734 - $576,924
60,159 New
60,159 $524,000
Q4 2021

Feb 08, 2022

SELL
$3.23 - $4.6 $35,823 - $51,018
-11,091 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$3.47 - $4.42 $16,756 - $21,344
-4,829 Reduced 30.33%
11,091 $40,000
Q2 2021

Aug 11, 2021

BUY
$3.94 - $4.92 $62,724 - $78,326
15,920 New
15,920 $69,000
Q4 2020

Feb 12, 2021

SELL
$5.73 - $9.03 $255,546 - $402,719
-44,598 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$3.32 - $7.24 $148,065 - $322,889
44,598 New
44,598 $323,000
Q1 2020

Apr 21, 2020

SELL
$1.25 - $2.02 $16,547 - $26,740
-13,238 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$1.33 - $5.93 $17,606 - $78,501
13,238 New
13,238 $26,000
Q2 2018

Jul 30, 2018

SELL
$10.66 - $14.38 $153,738 - $207,388
-14,422 Closed
0 $0
Q1 2018

Apr 16, 2018

BUY
$9.0 - $15.16 $129,798 - $218,637
14,422 New
14,422 $187,000

Others Institutions Holding CBAY

About CymaBay Therapeutics, Inc.


  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.